Welcome to our dedicated page for Innovex International SEC filings (Ticker: INVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Innovex International, Inc. filings document formal disclosures for an oil and gas well-products company formed from the Dril-Quip and Innovex Downhole Solutions merger. Recent 8-K reports furnish quarterly results, earnings presentations and non-GAAP reconciliations, while proxy materials cover annual meeting matters, board governance and executive compensation.
The filing record also includes material-event disclosures on common-stock offering agreements by selling stockholders, share repurchase activity under the company's repurchase program, director changes and litigation involving Downhole Well Solutions, LLC, a wholly owned subsidiary, and friction-reduction tools used in directional drilling.
Innovex International, Inc. reported that investment funds affiliated with Amberjack Capital Partners sold a total of 6,612,500 shares of Innovex common stock in open-market-style transactions tied to an underwritten secondary offering. The shares were sold at a public price of $25.75 per share, with the funds receiving $24.59125 per share after underwriting discounts. Individual transactions included 4,902,244 shares sold by Amberjack Capital Fund II, L.P., 1,144,635 shares by Innovex Co-Invest Fund II, L.P., 271,279 shares by Innovex Co-Invest Fund, L.P., and smaller blocks by Intervale Capital Fund II, L.P., Intervale Capital Fund II-A, L.P., and Intervale Capital Fund III, L.P. After these sales, Amberjack Capital Fund II, L.P. held 16,871,374 Innovex shares, while Innovex Co-Invest Fund II, L.P. held 3,939,330 shares and Innovex Co-Invest Fund, L.P. held 933,624 shares.
Innovex International, Inc. supported a secondary share sale by major stockholders and simultaneously executed a share repurchase. Affiliates of Amberjack Capital Partners sold 5,750,000 shares of common stock at $25.75 per share, and underwriters exercised a 30-day option for an additional 862,500 shares. Innovex did not sell any shares or receive proceeds from this Offering. Instead, it repurchased 575,000 shares from the underwriters for about $14.1 million under its existing buyback program, leaving roughly $76.6 million available for future repurchases. A committee of independent directors approved the transaction, and both the Offering and repurchase closed on February 27, 2026.
Innovex International, Inc. is registering 5,750,000 shares of common stock for resale by the selling stockholders.
The company will not receive proceeds from these sales; the selling stockholders will receive the net proceeds at a public offering price of $25.75 per share. The underwriters’ discount is $1.15875 per share. Innovex intends, subject to the offering’s completion, to purchase the lesser of 10% (which would be 575,000 shares) and $15,000,000 of the shares being sold. The underwriters have an option to purchase up to 862,500 additional shares. The last reported sale price on the NYSE was $28.90 per share as of February 24, 2026.
Innovex International, Inc. Chief Executive Officer and director Adam Anderson reported an open-market sale of common stock. On February 24, 2026, he sold 18,837 shares of Innovex common stock at $28.50 per share in a transaction classified as a sale in the open market or a private transaction.
The filing states that all shares in this trade were sold at the reported price and that the sales were made pursuant to a pre-established Rule 10b5-1 trading plan adopted on March 14, 2025. After this transaction, Anderson’s directly held Innovex common stock position is 466,744 shares.
Innovex International, Inc. is registering the resale of 5,750,000 shares of its common stock by selling stockholders as set forth in a preliminary prospectus supplement dated February 25, 2026. The Company will receive no proceeds from these sales and has agreed to register up to 29,369,822 shares for resale under the base prospectus.
The prospectus supplement states the Company intends, subject to completion of the offering, to repurchase the lesser of 10% of the offered shares or $15,000,000 (which would equal 575,000 shares if repurchasing 10%). Shares outstanding were 69,138,690 shares as of February 24, 2026. The underwriters have a 30‑day option to purchase additional shares and lock-up and registration‑rights provisions apply to the selling stockholders and certain insiders.
Innovex International, Inc. Chief Executive Officer and director Adam Anderson reported an open-market sale of company stock. On February 23, 2026, he sold 13,241 shares of common stock at $27.00 per share under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2025.
After this transaction, Anderson directly owned 485,581 shares of Innovex International common stock. The filing specifies that all shares in this trade were sold at the stated price per share.
Innovex International, Inc. files its annual report describing a larger, more diversified oilfield technology business following a merger and several acquisitions. Legacy Innovex merged with Dril-Quip and the combined company bought majority stakes in Downhole Well Solutions, SCF Machining and Citadel Casing Solutions, adding cash-and-share funded deals across 2024–2025.
The company designs, manufactures, rents and services mission‑critical downhole tools used across the well lifecycle, with 2025 revenue split between North American and International/Offshore markets and weighted toward product sales. Management estimates an $8.0 billion addressable market and mid‑teens share in North America.
Innovex highlights a “No Barriers” culture, in‑house and outsourced manufacturing across several countries, and a large patent portfolio. The report also emphasizes extensive risk factors tied to oil and gas cyclicality, global expansion, regulation, climate and fracturing policies, supply chain, indebtedness, and compliance with trade and anti‑corruption laws.
INVX disclosure: A Rule 144 notice reports 18,837 common shares to be sold by the reporting person tied to a 01/01/2024 stock award. The filing lists prior permitted sales of 13,241 shares on 01/14/2026 for $331,025.00 and 13,241 shares on 02/23/2026 for $357,507.00. The securities are listed on NYSE and the covering notice is dated 02/24/2026.
Innovex International, Inc. reported strong fourth-quarter and full-year 2025 results, highlighted by Q4 revenue of $273,602,000, up 14% sequentially. Q4 net income was $13,968,000 with a 5% net margin, and Adjusted EBITDA reached $52,108,000 with a 19% margin.
For full-year 2025, revenue grew to $978,251,000 and income from operations was $132,625,000. The company generated Q4 Free Cash Flow of $43,311,000 and $155,780,000 for the year, ending 2025 with $203,407,000 in cash and cash equivalents and no bank debt. Management guided Q1 2026 revenue to $225,000,000–$235,000,000 and Adjusted EBITDA to $38,000,000–$42,000,000, noting lower subsea deliveries and a plan to improve subsea margins after exiting the Eldridge facility by the end of Q2 2026.
Issuer: INVX (NYSE) notice of proposed sale under Rule 144 involving common stock tied to a prior stock award.
Broker is UBS Financial Services, Inc.. The filing shows Adam Anderson reported sales of 331,025 common shares on 01/14/2026, and the securities originate from a stock award dated 12/31/2016.